DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant’s election without traverse of Claims 7-9 in the reply filed on 8/31/2026 is acknowledged.
Claims 1-6 and 10-14 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected groups, there being no allowable generic or linking claim.
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claims 7-9 are rejected under 35 U.S.C. 103 as being unpatentable over Choi (KR2016-0146259) and Azeredo NPL, both made of record by Applicant, and in view of Ajami et al. (USPA 2017/0105438)
Regarding Claim 7, Choi teaches a hydrogel comprising bio-cellulose derived from an Acetobacter bacteria (Embodiment 1, Page 12 of machine translation provided by Applicant), where the hydrogel comprises 1g of the biocellulose, 0.935 g of carrageenan and 0.035 of potassium chloride (Embodiment 1), where the hydrogel taught by Choi is seen to meet the limitation of a cultured meat scaffold, as claimed, in light of the claimed components being included. Reference is made to Claim 1, which recites the composition from which the cultured meat scaffold is made, where the composition comprises bio cellulose powder derived from Gluconacetobacter, a natural polymer gelling agent which can include carrageenan, and a gelling accelerator, which is met by the addition of potassium chloride. In particular, Choi teaches 1g of the bio cellulose which meets the range in Claim 1 of 1 parts by weight of bio cellulose, 0.935 g of carrageenan renders obvious to one of ordinary skill in the art the claimed amount of 1 part by weight of gelling agent. While Choi teaches a lower content of potassium chloride than claimed, Choi still teaches a cohesive hydrogel and teaches potassium chloride functions as a thickener in the hydrogel (Page 10). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to have optimized the amount of potassium chloride in the hydrogel, depending on the characteristics of the gel desired.
It is noted that to the extent that Choi does not teach the biocellulose powder as claimed, derived from Gluconacetobacter, Azeredo teaches that bacterial cellulose is commonly made from the genus Komagateibacter (formerly Gluconacetobacter) (Page 1, Column 1) and that bio cellulose powder has applications in the production of meat analogs (Page 7, Column 1). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention, for the bio cellulose taught by Choi to be made by Gluconacetobacter, in light of the teachings of Azeredo.
In addition, regarding the limitation of a cultured meat scaffold manufactured from the claimed composition, Ajami teaches meat like food products made from hydrogels, including cellulose, gelling agents, agar, carrageenan, etc. (Paragraph 199-201, Paragraph 203, Example 5 meat like foods using hydrogels). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to have used the hydrogel composition of Choi in view of Azeredo to prepare meat-like foods or cultured meat scaffolds, in light of the teachings of Ajami.
Regarding Claims 8 and 9, since Choi in view of Azeredo and Ajami teach and render obvious the claimed composition which is used to make up the claimed cultured meat scaffold, one of ordinary skill in the art would have reasonably expected the same components to behave as claimed, and therefore the bio cellulose component would be expected to behave as claimed and provide the claimed benefits, absent teachings to the contrary.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JENNA A WATTS whose telephone number is (571)270-7368. The examiner can normally be reached Monday-Friday. 9am-4:30pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
JENNA A. WATTS
Primary Examiner
Art Unit 1791
/JENNA A WATTS/Primary Examiner, Art Unit 1791 10/27/2026